Patents by Inventor Shantilal Dayaram Naker

Shantilal Dayaram Naker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vancoresmycin, a process for its production and its use as a pharmaceutical
    Publication number: 20020183267
    Abstract: The present invention relates to a compound named Vancoresmycin which is obtainable by cultivation of the microorganism HIL-006734 (DSM 12216), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Vancoresmycin, to the microorganism HIL-006734 (DSM 12216), to the use of Vancoresmycin and its pharmaceutically acceptable salts as pharmaceuticals, and in particular to their use as antibiotics, and to pharmaceutical compositions comprising Vancoresmycin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 25, 2002
    Publication date: December 5, 2002
    Inventors: Nirogi Venkata Satya Ramakrishna, Ravi Gaianan Bhat, Eyyammadichiyil Sankaranarayanan Sreekumar, Erra Koteswara Satya Vijayakumar, Shantilal Dayaram Naker, Uttara Vinayak Oak, Rajendra Prakash Tanpure, Cordula Hopmann, Michael Kurz, Joachim Wink, Gerhard Seibert, Dominique Le Beller, Jozsef Aszodi
  • Vancoresmycin, a process for its production and its use as a pharmaceutical
    Patent number: 6387943
    Abstract: The present invention relates to a compound named Vancoresmycin which is obtainable by cultivation of the microorganism HIL-006734 (DSM 12216), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Vancoresmycin, to the microorganism HIL-006734 (DSM 12216), to the use of Vancoresmycin and its pharmaceutically acceptable salts as pharmaceuticals, and in particular to their use as antibiotics, and to pharmaceutical compositions comprising Vancoresmycin or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: May 14, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Nirogi Venkata Satya Ramakrishna, Ravi Gajanan Bhat, Eyyammadichiyil Sankaranarayanan Sreekumar, Erra Koteswara Satya Vijayakumar, Shantilal Dayaram Naker, Uttara Vinayak Oak, Rajendra Prakash Tanpure, Cordula Hopmann, Michael Kurz, Joachim Wink, Gerhard Seibert, Dominique Le Beller, Jozsef Aszodi